CANDRIAM S.C.A. – Cytokinetics, Incorporated Transaction History
CANDRIAM S.C.A. portfolio value:
$24.38M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
+23.31%
quarter
Cytokinetics, Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -3.31% | -17.23K shares | 3.93M | $48.45 | 503.24K |
| Q2 2022 | share | Decrease | -18.70% | -119.75K shares | -3.11M | $39.29 | 520.47K |
| Q1 2022 | share | Increase | +24.72% | 126.88K shares | 168K | $36.81 | 640.22K |
| Q4 2021 | share | 0.00% | 0 shares | 5.05M | $45.6 | 513.34K | |
| Q3 2021 | share | 0.00% | 0 shares | 8.18M | $35.74 | 513.34K | |
| Q2 2021 | share | Increase | +36.58% | 137.49K shares | 2.65M | $19.79 | 513.34K |
| Q1 2021 | share | 0.00% | 0 shares | -309K | $23.26 | 375.85K | |
| Q4 2020 | share | Increase | +168.04% | 235.62K shares | 4.77M | $20.78 | 375.85K |
| Q3 2020 | share | Increase | 0.00% | 140.22K shares | 3.03M | $21.65 | 140.22K |